Home
/
Organogenesis Holdings Inc.
/
Financials
/
Quarterly
Organogenesis Holdings Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Organogenesis Holdings Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$150.86M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$101.01M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$86.69M
May 8, 2025
Q3
2025
Sep 30, 2024
$115.18M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$130.23M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$109.98M
May 8, 2025
Q3
2024
Sep 30, 2023
$108.53M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$117.32M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$107.64M
May 9, 2024
Q3
2023
Sep 30, 2022
$116.86M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$121.40M
Aug 9, 2023
Q2
2022
Mar 31, 2022
$97.12M
Aug 9, 2022
Q3
2022
Mar 31, 2022
$97.12M
Nov 9, 2022
Q1
2023
Mar 31, 2022
$97.12M
May 10, 2023
Q3
2022
Dec 31, 2021
$467.36M
Nov 9, 2022
Q2
2022
Dec 31, 2021
$467.36M
Aug 9, 2022
Q3
2022
Sep 30, 2021
$113.75M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$123.20M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$102.55M
May 10, 2022
Q3
2021
Sep 30, 2020
$100.80M
Nov 9, 2021
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2018
Sep 30, 2018
$0
Nov 9, 2018
Q2
2018
Jun 30, 2018
$0
Aug 7, 2018
Q1
2018
Mar 31, 2018
$0
May 10, 2018
Q3
2017
Sep 30, 2017
$0
Nov 14, 2017
Q2
2017
Jun 30, 2017
$0
Aug 11, 2017
Q1
2017
Mar 31, 2017
$0
May 12, 2017
Q3
2016
Sep 30, 2016
$0
Nov 18, 2016
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$21.57M
Nov 6, 2025
Q2
2025
Jun 30, 2025
($9.39M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($18.84M)
May 8, 2025
Q3
2025
Sep 30, 2024
$12.33M
Nov 6, 2025
Q2
2025
Jun 30, 2024
($17.04M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($2.10M)
May 8, 2025
Q3
2024
Sep 30, 2023
$3.17M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$5.32M
Aug 8, 2024
Q1
2024
Mar 31, 2023
($2.97M)
May 9, 2024
Q3
2023
Sep 30, 2022
$215.0K
Nov 9, 2023
Q2
2023
Jun 30, 2022
$8.74M
Aug 9, 2023
Q3
2022
Mar 31, 2022
($913.0K)
Nov 9, 2022
Q2
2022
Mar 31, 2022
($913.0K)
Aug 9, 2022
Q1
2023
Mar 31, 2022
($913.0K)
May 10, 2023
Q3
2022
Dec 31, 2021
$94.20M
Nov 9, 2022
Q2
2022
Dec 31, 2021
$94.20M
Aug 9, 2022
Q3
2022
Sep 30, 2021
$12.58M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$20.69M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$9.94M
May 10, 2022
Q3
2021
Sep 30, 2020
$20.76M
Nov 9, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$20.73M
Nov 6, 2025
Q2
2025
Jun 30, 2025
($12.58M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($26.75M)
May 8, 2025
Q3
2025
Sep 30, 2024
$6.24M
Nov 6, 2025
Q2
2025
Jun 30, 2024
($13.89M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($3.85M)
May 8, 2025
Q3
2024
Sep 30, 2023
$8.05M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$9.75M
Aug 8, 2024
Q1
2024
Mar 31, 2023
($4.00M)
May 9, 2024
Q3
2023
Sep 30, 2022
$1.78M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$11.94M
Aug 9, 2023
Q1
2023
Mar 31, 2022
($128.0K)
May 10, 2023
Q2
2022
Mar 31, 2022
($128.0K)
Aug 9, 2022
Q3
2022
Mar 31, 2022
($128.0K)
Nov 9, 2022
Q3
2022
Dec 31, 2021
$72.22M
Nov 9, 2022
Q2
2022
Dec 31, 2021
$72.22M
Aug 9, 2022
Q3
2022
Sep 30, 2021
$16.26M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$23.59M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$12.62M
May 10, 2022
Q3
2021
Sep 30, 2020
$22.80M
Nov 9, 2021